Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?

被引：12
作者：
Ilyas, Hajira [1 ]
Mikhaeel, N. George [2 ]
Dunn, Joel T. [3 ,4 ]
Rahman, Fareen [2 ]
Moller, Henrik [5 ]
Smith, Daniel [2 ]
Barrington, Sally F. [3 ,4 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, Dept Nucl Med, London, England
[2] Guys & St Thomas NHS Fdn Trust, Dept Clin Oncol, London, England
[3] KCL, 4th Floor Lambeth Wing,Westminster Bridge Rd, London SE1 7EH, England
[4] Kings Coll London, Guys & St Thomas PET Ctr, Sch Biomed Engn & Imaging Sci, St Thomas Hosp,Kings Hlth Partners, 4th Floor Lambeth Wing,Westminster Bridge Rd, London SE1 7EH, England
[5] Kings Coll London, Dept Canc Epidemiol & Populat Hlth, Kings Hlth Partners, London, England
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / 02期
基金：
英国工程与自然科学研究理事会;
关键词：
D O I：
10.1007/s00259-018-4200-3
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：520 / 521
页数：2
相关论文
共 50 条
[31]   A novel prognostic index for diffuse large B-cell lymphoma combined baseline metabolic tumour volume with clinical and pathological risk factors [J].
Yuan, T. ;
Chen, X. ;
Zhang, Y. ;
Wei, M. ;
Zhu, H. ;
Yang, Z. ;
Wang, X. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) :S302-S302
[32]   A novel prognostic index for diffuse large B-cell lymphoma combined baseline metabolic tumour volume with clinical and pathological risk factors [J].
Yuan, Tingting ;
Chen, Xuetao ;
Zhang, Yuewei ;
Wei, Maomao ;
Zhu, Hua ;
Yang, Zhi ;
Wang, Xuejuan .
NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (07) :622-630
[33]   Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory? [J].
Laffon, Eric ;
Marthan, Roger .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (10) :1832-1833
[34]   Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory? [J].
Eric Laffon ;
Roger Marthan .
European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 :1832-1833
[35]   Association of high baseline metabolic tumor volume with response following axicabtagene ciloleucel in refractory large B-cell lymphoma. [J].
Dean, Erin ;
Lu, Hong ;
Lazaryan, Aleksandr ;
Krivenko, Gabriel S. ;
Bachmeier, Christina A. ;
Chavez, Julio C. ;
Davila, Marco L. ;
Khimani, Farhad ;
Liu, Hien D. ;
Pinilla-Ibarz, Javier ;
Shah, Bijal D. ;
Jain, Michael D. ;
Balagurunathan, Yoganand ;
Locke, Frederick Lundry .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[36]   Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium [J].
Barrington, Sally F. ;
Zwezerijnen, Ben G. J. C. ;
de Vet, Henrica C. W. ;
Heymans, Martijn W. ;
Mikhaeel, N. George ;
Burggraaff, Coreline N. ;
Eertink, Jakoba J. ;
Pike, Lucy C. ;
Hoekstra, Otto S. ;
Zijlstra, Jose M. ;
Boellaard, Ronald .
JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (03) :332-337
[37]   Uncovering the metabolic vulnerabilities in activated B cell diffuse large B cell lymphoma [J].
Singh, Satishkumar ;
Choueiry, Fouad ;
Sircar, Anuvrat ;
Epperla, Narendranath ;
Zhu, Jiangjiang ;
Sehgal, Lalit .
CANCER RESEARCH, 2023, 83 (07)
[38]   The prognostic significance of whole-body and spleen MTV (metabolic tumor volume) scanning for patients with diffuse large B cell lymphoma [J].
Yamanaka, Shintaro ;
Miyagawa, Masao ;
Sugawara, Yoshifumi ;
Hasebe, Shinji ;
Fujii, Tomomi ;
Takeuchi, Kazuto ;
Tanaka, Keiko ;
Yakushijin, Yoshihiro .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (01) :225-232
[39]   A focus on the impact of spleen involvement in total metabolic tumor volume measurements in Diffuse Large B-Cell Lymphoma patients. [J].
Rebaud, L. ;
Capobianco, N. ;
Girum, K. ;
Cottereau, A. ;
Morschhauser, F. ;
Spottiswoode, B. ;
Buvat, I. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) :S559-S559
[40]   Metabolic tumor volume on interim PET is a better predictor of outcome in diffuse large B-cell lymphoma than semiquantitative methods [J].
E Malek ;
A Sendilnathan ;
M Yellu ;
A Petersen ;
M Fernandez-Ulloa ;
J J Driscoll .
Blood Cancer Journal, 2015, 5 :e326-e326
12345